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Parki nson disease (PD) is highly prevalent, and it has been estimated that 85Y187 cases per 100,000 inhabitants occur within the age range of 50Y70 yrs. 1 PD has a variety of manifestations and produces progressive functional impairment. 2 The characteristic clinical signs are tremors while at rest, rigidity, bradykinesia, and postural instability. At least two of these signs are needed to make the diagnosis. 3 The secondary abnormalities include difficulty in walking (festination), micrography, amimic facies, dysarthria, dysphagia, sialorrhea, depression, sleep disorders, cognitive dysfunction, and memory loss in more advanced cases. 2, 3 Postural instability causes great loss of the ability to walk, and this is because of loss of interaction between the vestibular, visual, and proprioceptive systems. 2 Quality-of-life of PD patients thus becomes greatly compromised through lower functional independence. 4 The effects of PD on postural sway characteristics appear unclear, with studies reporting increases, 5 decreases, 6 or no differences, 7 partly because of the difficulty in distinguishing between the disease process and the compensatory mechanisms. Colnat-Coulbois et al. 8 found that in static posturography testing, patients with PD showed reduced postural control precision with increased oscillations in both anterior-posterior and medial-lateral planes, compared with the healthy control subjects. Ickenstein et al. 9 showed that people with PD have larger postural sway than do elderly people during the platform Romberg test with closed eyes, quantified with static posturography testing.
The current treatments for PD deal with the symptoms and do not impede its progression. The drug most used for this is levodopa/benserazide. 10 Some surgical procedures are also performed, such as stereotaxic pallidotomy and thalamotomy 11 and deep brain stimulation. 12 Kinesiotherapy programs may stimulate dopamine release in the remaining dopaminergic cells and help to maintain the motor repertory of activities of daily living, walking, and functional balance. 13 Treatment with levodopa/benserazide or dopaminergic agonists is effective during the initial phases of the disease, but it loses efficacy as the disease evolves and, after a few years (5Y7 yrs), patients may present motor complications produced by dyskinesia. 14 The authors did not find studies that showed the effects of dopaminergic drugs on balance evaluated by posturography methods in patients in late stages of the disease, and thus, the aims of the present study were to compare the postural balance of PD patients with and without the effects from dopaminergic medication and to ascertain these patients' axis of greatest displacement. Twenty-three individuals with PD were assessed. One individual was excluded from this study because of inability to accomplish the tests, and thus, 22 individuals were included in this study. Their mean T SD age was 58.38 T 11.09 yrs (range, 53Y75), 17 were men and 5 were women, and the mean T SD duration of symptoms was 17.81 T 4.97 yrs.
METHODS
The inclusion criteria were a clinical diagnosis of idiopathic PD in accordance with the international criteria 15 ; intellectual capability of comprehending and signing the consent statement; having been recruited at the neurology service of Hospital das Clínicas, University of São Paulo School of Medicine (HC-FMUSP), and awaiting an operation for implantation of a deep brain stimulator; being older than 18 yrs; absence of infections or other preexisting noncontrolled medical conditions (diabetes, hypertension, lung disease, or symptomatic cardiac disease); lack of vestibular diseases or visual disturbances; and having previous data analyzed by a neurologist.
All patients were instructed not to take the dopaminergic medication (levodopa) for at least 12 hrs before the assessment.
The first balance assessment was made without the medication. After this, all the patients took Prolopa at their habitual dose and then repeated the same test 30 mins later (test with medication). All the participants stayed standing upright on both feet, on a portable force platform: the AccuSway Plus model (Advanced Mechanical Technology Inc, Watertown, MA).
The physical dimension used in the tests was the center of pressure (CP). To analyze postural balance, ground reaction forces and swaying from the CP were recorded. For this, forces and moments were recorded by the platform in three directions: mediolateral (X), anteroposterior (Y), and vertical (Z). The calculations were done using the CP positions in the anteroposterior and mediolateral directions. The Balance Clinic software was used for the data acquisition, configured at a frequency of 100 Hz with a fourth-order Butterworth low-pass filter cutoff frequency of 10 Hz.
Positioning
Before conducting the assessments, the subjects stepped onto the platform without shoes and took up the foot positions that would be used. The weight-bearing base thus established was not allowed to be greater than the width of the subject's hips. During the tests, all patients remained in the pre-established area. The foot positions were marked out on a sheet of paper that had been attached to the platform. Four points were marked on each foot: the hallux, the head of the fifth metatarsal, the lateral malleolus, and the medial malleolus. This base was registered in the software and was then used in all the tests, after applying a force of 10 lbs at each of the points marked on the sheet of paper.
Assessment
The assessments were made with the subjects standing on two feet on the platform, with their heels separated and kept in a comfortable position, as marked on the sheet of paper. Their arms were static and kept along the sides of the body, and their eyes were fixed on a point 1 m in front of them that was 10 cm lower than their height. After positioning and guidance, the verbal command for the test to start was given. The data recording was started 5 secs later so that the initial swaying would be discarded. At each of the attempts (with the eyes open or closed), the subjects were instructed to try to prevent movement. Three tests were done with the eyes open; and three, with the eyes closed, each with a duration of 60 secs.
After each test, the data were saved and the zero point of the platform was reset for the next test. The results were given as the arithmetic mean of the three tests that were performed under each condition, as processed automatically by the Balance Clinic analysis software.
Data Analysis
The CP displacements were calculated in accordance with the respective directions, by means of the root mean square. The stability measurement parameters under the conditions of eyes open and eyes closed, with and without medication, were the following: & mean amplitude of CP displacement in the anteroposterior plane (Y) and the mediolateral plane (X) & resultant mean velocity, calculated by dividing the total CP displacement in all directions by the time period & elliptical area of 95% of the displacement, calculated such that 95% of all the CP displacements would be inside this ellipse
Statistical Analysis
The data were stored and analyzed in the Bio Statistic software. Descriptive analysis was performed on the study sample by means of tables. The Shapiro-Wilk test was used to ascertain whether the continuous variables presented normal distribution. The paired Student's t test was applied to make comparisons between the postures, standing on two feet with the eyes open and closed and with and without medication. Table 1 shows the results under the condition of eyes open. There were no statistically significant differences in the mediolateral displacement, the anteroposterior displacement, or the displacement velocity. The elliptical area was bigger in the group with medication (P = 0.006). Table 2 shows the results found under the condition of eyes closed. There were no statistically significant differences in the mediolateral displacement, the anteroposterior displacement, or the displacement velocity. The elliptical displacement area was bigger in the group with medication (P = 0.003). Table 3 shows the comparison between the displacements along the anteroposterior and mediolateral axes, under the conditions of eyes open and eyes closed. There was more displacement along the anteroposterior axis.
RESULTS

DISCUSSION
PD compromises activities of daily living, 16 with a highly negative impact on such patients' quality-oflife. Walking disorders and postural instability contribute significantly toward this loss of quality-of-life. 15 Effective treatments to improve balance and locomotion may be very beneficial for PD patients.
The use of balance assessment methods that are more precise, such as posturography, may improve the quality of the results assessment, thereby contributing toward making it possible to use procedures that are more effective. 17 The best measurement of balance is given by static posturography, which uses the CP, that is, the point at which the resultant from the vertical forces acting on the load-bearing surface is applied. The Accusway platform that was used in this study was considered to be reliable for assessment (intraclass correlation coefficient of 90.75) in previously published studies. 18 Even though clinical tests may show changes in balance that are caused by dopaminergic drugs, the types of changes that occur are shown by instrumented evaluations. In the present study, it was observed that there was a large increase in sway area among the patients when they were under the effects of levodopa. The increase in this area was easily correlatable with dyskinesia because the change in movement quality impaired the patients' balance reactions, thus obliging them to make displacements over a wider area to remain on their feet. Thus, real situations that do not allow this type of adaptation may contribute toward the falls that are observed among PD patients. 19 In a case study with kinematic analysis on walking with and without dopaminergic medication, Ferreira et al. 20 showed that motor control was better after the medication had been administered but reported that there were increases in dyskinesia and postural imbalance. Dynamic assessment of walking, using kinematic parameters that relate drectly to muscle tonus and the capacity to generate movements among patients under the effects of medication, is better. Several posturographic studies refer that balance abnormalities are equal to the larger postural sway, 21 but these results are controversial because the increased movement of the COP could be one of the strategies to maintain the balance and prevent falls. However, major deficit of postural orientation develops earlier than equilibrium deficit does in PD patients and uses inadequate postural strategies, leading to falls. 22 Because peripheral inputs are intact in PD, postural instability seems to result from abnormal central processing of this information, leading to inadequate postural response. 23 Levodopa improves the tremors and the rigidity but may worsen postural instability 24 and causes other side effects such as nausea, diarrhea, and dyskinesia. Seventy percent of the patients who use levodopa for 6 yrs or more have motor complications and need to temporarily suspend their use of it (Boff effect[). 25 The off effect is caused by a decrease in available dopamine that occurs before the next dose and is caused by diminished capacity of the nervous system to store and release dopamine, thereby requiring individual adjustments of dosage and intake frequency. 25 A group of PD patients who were awaiting surgery to implant a deep brain stimulator were followed up for 4 yrs. The drugs used by this group were levodopa and pramipexole. Seventy-four percent of the individuals who were using levodopa showed dyskinesia and on-off effects. Although the study did not correlate the medication with side effects, the surgical indication for these patients showed that there was excessive presence of dyskinesia and on-off effects, given that this operation is indicated to minimize the adverse effects of the medications and reduce the dosage used. 12 The authors observed that the displacement was greater along the anteroposterior axis than along the mediolateral axis, with posterior displacement predominating. This result was similar to the findings of Dutra Filho et al., 26 who used a sway meter in their study. Abe et al. 2 used photogrammetry and reported that there was greater anterior than posterior sway. The differences in the measurement systems and patient profiles may explain these divergent results. Greater anteroposterior displacement may be explained by the PDrelated postural alterations, with predominance of trunk flexor action and displacement of the center of gravity anteriorly. 26 Studies with posturography show that parkinsonian subjects, compared with the healthy elderly, have increase in lateral and anterior-posterior sway range. 5, 8 Mitchell et al. 27 observed an increase in the mediolateral direction. Mediolateral posturographic measures were also associated with a history of falls and poor performance on clinical measures of balance. It was hypothesized that the increase in mediolateral activity in subjects with idiopathic PD may reflect an attempt to maintain potentially stabilizing movements during quiet standing in the face of impaired movement in the anteroposterior direction. However, there is no consensus that the impairment mediolateral posturographic measures are more significant. The cell loss in the locus coeruleus and a resultant central norepinephrine deficit are intimately involved in the pathophysiology of postural instability in PD. Difficulties in managing complex postural situations, such as sensory conflicting and dynamic situations, might reflect an inadequate sensory organization, suggesting impairment in central information processing. 8 Within this context, studies such as those of Takeuti et al. 19 showed that balance deficiencies are responsible for the falls among PD patients and that such falls are correlated with greater severity of the disease (Hoehn and Yahr scale). These authors reported that the length of evolution of the disease had little influence on occurrences of falls. Falls are serious events for elderly people and even more so in PD cases. Identification of factors that compromise balance is very important for preventing falls. 16 Vieira et al. 28 compared the balance of healthy elderly people with that of PD patients using a stability meter. The mean displacement area among the PD patients was 8.55 cm 2 , vs. 2.96 cm 2 among the healthy elderly people, thus showing that the PD patients were at greater risk for falls. Mata et al. 29 showed that 75% of the patients with moderate PD and 100% of those with severe PD presented a high risk for falls, as assessed using the Tinetti and Webster scale. The association with greater disease severity, thus requiring higher doses of medication, which could lead to dyskinesia and worsened postural balance, is the best explanation for the observation that 100% of the patients with severe PD were at a high risk for falls, even though these authors did not make a reference to the medication in their study. Gray and Hildebrand 30 assessed the risk for falls among 118 PD patients and reported that 59% had already had at least one fall and that 21% of the falls were associated with dyskinesia alone.
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